Molecular analysis of some camel cytochrome P450 enzymes reveals lower evolution and drug-binding properties

References

• Abu Damir, H., Ali, M. A., Abbas, T., Omer, E., & Al Fihail, A. (2013). Narasin poisoning in the dromedary camel (Camelus dromedarius). Comparative Clinical Pathology, 22, 305–311.
   Google Scholar
• Ali, B. H. (1988). A survey of some drugs commonly used in the camel. Veterinary Research Communications, 12, 67–75.10.1007/BF00396405
   PubMed Web of Science ®Google Scholar
• Alquarawi, A. A., & Ali, B. H. (2000). A survey of the literature (1995–1999) on the kinetics of drugs in camels (Camelus dromedarius). Veterinary Research Communications, 24, 245–260.10.1023/A:1006498816669
   PubMed Web of Science ®Google Scholar
• Badr, G. (2013). Camel whey protein enhances diabetic wound healing in a streptozotocin-induced diabetic mouse model: The critical role of β-Defensin-1, -2 and -3. Lipids in Health and Disease, 12, 46.10.1186/1476-511X-12-46
   PubMed Web of Science ®Google Scholar
• Burger, P. A., & Palmieri, N. (2014). Estimating the population mutation rate from a de novo assembled Bactrian camel genome and cross-species comparison with dromedary ESTs. Journal of Heredity, 105, 839–846.10.1093/jhered/est005
   PubMed Web of Science ®Google Scholar
• Di Rocco, F., Parisi, G., Zambelli, A., & Vida-Rioja, L. (2006). Rapid evolution of cytochrome c oxidase subunit II in camelids (Tylopoda, Camelidae). Journal of Bioenergetics and Biomembranes, 38, 293–297.10.1007/s10863-006-9048-8
   PubMed Web of Science ®Google Scholar
• Di Rocco, F., Zambelli, A. D., & Vidal Rioja, L. B. (2009). Identification of camelid specific residues in mitochondrial ATP synthase subunits. Journal of Bioenergetics and Biomembranes, 41, 223–228.10.1007/s10863-009-9221-y
   PubMed Web of Science ®Google Scholar
• Drummond, A. J., & Rambaut, A. (2007). BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evolutionary Biology, 7, 214.10.1186/1471-2148-7-214
   PubMed Web of Science ®Google Scholar
• Drummond, A. J., Suchard, M. A., Xie, D., & Rambaut, A. (2012). Bayesian phylogenetics with BEAUti and the BEAST 1.7. Molecular Biology and Evolution, 29, 1969–1973.10.1093/molbev/mss075
   PubMed Web of Science ®Google Scholar
• el Bahri, L., Souilem, O., Djegham, M., & Belguith, J. (1999). Toxicity and adverse reactions to some drugs in dromedary (Camelus dromedarius). Veterinary and Human Toxicology, 41, 35–38.
   PubMedGoogle Scholar
• Fraile, S., Jimenez, J. I., Gutierrez, C., & de Lorenzo, V. (2013). NanoPad: An integrated platform for bacterial production of camel nanobodies aimed at detecting environmental biomarkers. Proteomics, 13, 2766–2775.
   PubMed Web of Science ®Google Scholar
• Homeida, A. M., El Amin, E. A., Adam, S. E., & Mahmoud, M. M. (1981). Toxicity of diminazene aceturate (Berenil) to camels. Journal of Comparative Pathology, 91, 355–360.10.1016/0021-9975(81)90005-0
   PubMed Web of Science ®Google Scholar
• Kandeel, M., Al-Taher, A., Nakashima, R., Sakaguchi, T., Kandeel, A., Nagaya, Y., … Kitade, Y. (2014). Bioenergetics and gene silencing approaches for unraveling nucleotide recognition by the human EIF2C2/Ago2 PAZ domain. PLoS ONE, 9, e94538.10.1371/journal.pone.0094538
   PubMed Web of Science ®Google Scholar
• Kandeel, M., & Kitade, Y. (2013a). Computational analysis of siRNA recognition by the Ago2 PAZ domain and identification of the determinants of RNA-induced gene silencing. PLoS ONE, 8, e57140.10.1371/journal.pone.0057140
   PubMed Web of Science ®Google Scholar
• Kandeel, M., & Kitade, Y. (2013b). In silico molecular docking analysis of the human Argonaute 2 PAZ domain reveals insights into RNA interference. Journal of Computer-Aided Molecular Design, 27, 605–614.10.1007/s10822-013-9665-3
   PubMed Web of Science ®Google Scholar
• Köhler-Rollefson, I. (1993). About camel breeds: A reevaluation of current classification systems. Journal of Animal Breeding and Genetics, 110, 66–73.10.1111/jbg.1993.110.issue-1-6
   PubMed Web of Science ®Google Scholar
• Korish, A. A. (2014). The antidiabetic action of camel milk in experimental type 2 diabetes mellitus: An overview on the changes in incretin hormones, insulin resistance, and inflammatory cytokines. Hormone and Metabolic Research, 46, 404–411.
   PubMed Web of Science ®Google Scholar
• Miller, R. E., Boever, W. J., Junge, R. E., Thornburg, L. P., & Raisbeck, M. F. (1990). Acute monensin toxicosis in stone sheep (Ovis dalli stonei), blesbok (Damaliscus dorcus phillipsi), and a Bactrian camel (Camelus bactrianus). Journal of the American Veterinary Medical Association, 196, 131–134.
   PubMed Web of Science ®Google Scholar
• Mousa, H. M., & Elsheikh, H. A. (1992). Monensin poisoning in dromedary camels. Deutsche Tierarztliche Wochenschrift, 99, 464.
   PubMedGoogle Scholar
• Nebbia, C., Ceppa, L., Dacasto, M., Carletti, M., & Nachtmann, C. (1999). Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: Evidence for the involvement of cytochrome P-450 3A subfamily. Drug Metabolism and Disposition, 27, 1039–1044.
   PubMed Web of Science ®Google Scholar
• Nebbia, C., Ceppa, L., Dacasto, M., Nachtmann, C., & Carletti, M. (2001). Oxidative monensin metabolism and cytochrome P450 3A content and functions in liver microsomes from horses, pigs, broiler chicks, cattle and rats. Journal of Veterinary Pharmacology and Therapeutics, 24, 399–403.
   PubMed Web of Science ®Google Scholar
• Unciti-Broceta, J. D., Del Castillo, T., Soriano, M., Magez, S., & Garcia-Salcedo, J. A. (2013). Novel therapy based on camelid nanobodies. Therapeutic Delivery, 4, 1321–1336.10.4155/tde.13.87
   PubMedGoogle Scholar
• Wu, H., Guang, X., Al-Fageeh, M. B., Cao, J., Pan, S., Zhou, H., … Yang, H. (2014). Camelid genomes reveal evolution and adaptation to desert environments. Nature Communications, 5, Art. Id: 5188.10.1038/ncomms6188
   Web of Science ®Google Scholar